Cover Image
市場調查報告書

革蘭氏陽性菌菌感染症:全球臨床實驗檢討

Gram-Positive Bacterial Infections Global Clinical Trials Review, H2, 2014

出版商 GlobalData 商品編碼 320832
出版日期 內容資訊 英文 109 Pages
訂單完成後即時交付
價格
Back to Top
革蘭氏陽性菌菌感染症:全球臨床實驗檢討 Gram-Positive Bacterial Infections Global Clinical Trials Review, H2, 2014
出版日期: 2014年11月30日 內容資訊: 英文 109 Pages
簡介

本報告提供革蘭氏陽性菌菌感染症的臨床試驗相關之基本資料及數據,為您彙整實驗數量及受驗者的募集情況,各階段趨勢,臨床試驗的主要製藥企業及研究機關簡介等資料。

簡介

  • 革蘭氏陽性菌菌感染症
  • 本報告概要

各地區的臨床實驗情形

  • 各國臨床實驗數量和平均實驗人數
    • 亞太地區的主要5個國家的臨床實驗數量
    • 歐洲的主要5個國家的臨床實驗數量
    • 北美的主要國家的臨床實驗數量
    • 中東·非洲的主要5個國家臨床實驗數量
    • 中南美的主要5個國家臨床實驗數量

G7各國臨床實驗數量:感染症臨床實驗上革蘭氏陽性菌菌感染症所佔的比例

G7各國的各階段臨床實驗數量

G7各國臨床實驗數量:各進展狀況

E7各國臨床實驗數量:感染症臨床實驗上革蘭氏陽性菌菌感染症所佔的比例

E7各國的各階段臨床實驗數量

E7各國臨床實驗數量:各進展狀況

各階段臨床實驗數量

  • 進行中的臨床實驗:各階段

各進展狀況臨床實驗數量

臨床實驗上目標達成情形

未完成的臨床實驗數量

一定期間所採用的實驗對象

贊助商類別的臨床實驗數量

有潛力的贊助商

革蘭氏陽性菌菌感染症治療藥臨床實驗的主要參與企業

有潛力的藥劑

臨床實驗簡介

  • 主要企業臨床實驗概要
    • GlaxoSmithKline plc
    • Pfizer Inc.
    • Sanofi
    • Merck & Co., Inc.
    • Cubist Pharmaceuticals, Inc.
    • Novartis AG
    • Theravance, Inc.
    • AstraZeneca PLC
    • Emergent BioSolutions Inc.
    • Astellas Pharma Inc.
  • 有代表性的研究機關·醫院臨床實驗概要
    • The National Institute of Allergy and Infectious Diseases
    • University of Oxford
    • Health Protection Agency
    • Assistance Publique - Hopitaux de Paris
    • John D. Dingell VA Medical Center
    • University of Pittsburgh
    • Uniformed Services University of the Health Sciences
    • Johns Hopkins University
    • Duke University
    • Centers for Disease Control and Prevention

5個有代表性的臨床實驗簡介

附錄

目錄
Product Code: GDHC2445CTIDB

GlobalData's clinical trial report, "Gram-Positive Bacterial Infections Global Clinical Trials Review, H2, 2014" provides data on the Gram-Positive Bacterial Infections clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Gram-Positive Bacterial Infections. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Gram-Positive Bacterial Infections. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

  • Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each
  • Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type
  • Listings of discontinued trials (suspended, withdrawn and terminated)

Reasons to buy

  • Understand the dynamics of a particular indication in a condensed manner
  • Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more
  • Obtain discontinued trial listing for trials across the globe
  • Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies

Table of Contents

  • Table of Contents
    • List of Tables
    • List of Figures
  • Introduction
    • Gram-Positive Bacterial Infections
    • Report Guidance
  • Clinical Trials by Region
    • Clinical Trials and Average Enrollment by Country
      • Top Five Countries Contributing to Clinical Trials in Asia-Pacific
      • Top Five Countries Contributing to Clinical Trials in Europe
      • Top Countries Contributing to Clinical Trials in North America
      • Top Five Countries Contributing to Clinical Trials in Middle East and Africa
      • Top Five Countries Contributing to Clinical Trials in Central and South America
  • Clinical Trials by G7 Countries: Proportion of Gram-Positive Bacterial Infections to Infectious Disease Clinical Trials
  • Clinical Trials by Phase in G7 Countries
  • Clinical Trials in G7 Countries by Trial Status
  • Clinical Trials by E7 Countries: Proportion of Gram-Positive Bacterial Infections to Infectious Disease Clinical Trials
  • Clinical Trials by Phase in E7 Countries
  • Clinical Trials in E7 Countries by Trial Status
  • Clinical Trials by Phase
    • In Progress Trials by Phase
  • Clinical Trials by Trial Status
  • Clinical Trials by End Point Status
  • Unaccomplished Trials of Gram-Positive Bacterial Infections
  • Subjects Recruited Over a Period of Time
  • Clinical Trials by Sponsor Type
  • Prominent Sponsors
    • Top Companies Participating in Gram-Positive Bacterial Infections Therapeutics Clinical Trials
  • Prominent Drugs
  • Clinical Trial Profiles
    • Clinical Trial Overview of Top Companies
      • GlaxoSmithKline plc
      • Clinical Trial Overview of GlaxoSmithKline plc
      • Pfizer Inc.
      • Clinical Trial Overview of Pfizer Inc.
      • Sanofi
      • Clinical Trial Overview of Sanofi
      • Merck & Co., Inc.
      • Clinical Trial Overview of Merck & Co., Inc.
      • Cubist Pharmaceuticals, Inc.
      • Clinical Trial Overview of Cubist Pharmaceuticals, Inc.
      • Novartis AG
      • Clinical Trial Overview of Novartis AG
      • Theravance, Inc.
      • Clinical Trial Overview of Theravance, Inc.
      • AstraZeneca PLC
      • Clinical Trial Overview of AstraZeneca PLC
      • Emergent BioSolutions Inc.
      • Clinical Trial Overview of Emergent BioSolutions Inc.
      • Astellas Pharma Inc.
      • Clinical Trial Overview of Astellas Pharma Inc.
    • Clinical Trial Overview of Top Institutes / Government
      • The National Institute of Allergy and Infectious Diseases
      • Clinical Trial Overview of The National Institute of Allergy and Infectious Diseases
      • University of Oxford
      • Clinical Trial Overview of University of Oxford
      • Health Protection Agency
      • Clinical Trial Overview of Health Protection Agency
      • Assistance Publique - Hopitaux de Paris
      • Clinical Trial Overview of Assistance Publique - Hopitaux de Paris
      • John D. Dingell VA Medical Center
      • Clinical Trial Overview of John D. Dingell VA Medical Center
      • University of Pittsburgh
      • Clinical Trial Overview of University of Pittsburgh
      • Uniformed Services University of the Health Sciences
      • Clinical Trial Overview of Uniformed Services University of the Health Sciences
      • Johns Hopkins University
      • Clinical Trial Overview of Johns Hopkins University
      • Duke University
      • Clinical Trial Overview of Duke University
      • Centers for Disease Control and Prevention
      • Clinical Trial Overview of Centers for Disease Control and Prevention
  • Five Key Clinical Profiles
  • Appendix
    • Abbreviations
    • Definitions
    • Research Methodology
    • Secondary Research
    • About GlobalData
    • Contact Us
    • Disclaimer
    • Source

List of Tables

  • Gram-Positive Bacterial Infections Therapeutics, Global, Clinical Trials by Region, 2014*
  • Gram-Positive Bacterial Infections Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2014*
  • Gram-Positive Bacterial Infections Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2014*
  • Gram-Positive Bacterial Infections Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2014*
  • Gram-Positive Bacterial Infections Therapeutics Clinical Trials, Europe, Top Five Countries, 2014*
  • Gram-Positive Bacterial Infections Therapeutics Clinical Trials, North America, Top Countries, 2014*
  • Gram-Positive Bacterial Infections Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries, 2014*
  • Gram-Positive Bacterial Infections Therapeutics Clinical Trials, Central and South America, Top Five Countries, 2014*
  • Proportion of Gram-Positive Bacterial Infections to Infectious Disease Clinical Trials, G7 Countries (%), 2014*
  • Gram-Positive Bacterial Infections Therapeutics, G7 Countries, Clinical Trials by Phase, 2014*
  • Gram-Positive Bacterial Infections Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2014*
  • Proportion of Gram-Positive Bacterial Infections to Infectious Disease Clinical Trials, E7 Countries (%), 2014*
  • Gram-Positive Bacterial Infections Therapeutics, E7 Countries, Clinical Trials by Phase, 2014*
  • Gram-Positive Bacterial Infections Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2014*
  • Gram-Positive Bacterial Infections Therapeutics, Global, Clinical Trials by Phase, 2014*
  • Gram-Positive Bacterial Infections Therapeutics, Global, Clinical Trials In Progress by Phase 2014*
  • Gram-Positive Bacterial Infections Therapeutics, Global, Clinical Trials by Trial Status, 2014*
  • Gram-Positive Bacterial Infections Therapeutics Clinical Trials, Global, by End Point Status, 2014*
  • Gram-Positive Bacterial Infections Therapeutics, Global, Suspended Clinical Trials, 2014*
  • Gram-Positive Bacterial Infections Therapeutics, Global, Withdrawn Clinical Trials, 2014*
  • Gram-Positive Bacterial Infections Therapeutics, Global, Terminated Clinical Trials, 2014*
  • Gram-Positive Bacterial Infections Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013
  • Gram-Positive Bacterial Infections Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2014*
  • Gram-Positive Bacterial Infections Therapeutics Clinical Trials, Global, Key Sponsors, 2014*
  • Gram-Positive Bacterial Infections Therapeutics Clinical Trials, Global, Top Companies by Phase, 2014*
  • Gram-Positive Bacterial Infections Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2014*
  • Gram-Positive Bacterial Infections Therapeutics Clinical Trials Market, Global, Clinical Trials by GlaxoSmithKline plc, 2014*
  • Gram-Positive Bacterial Infections Therapeutics Clinical Trials Market, Global, Clinical Trials by Pfizer Inc., 2014*
  • Gram-Positive Bacterial Infections Therapeutics Clinical Trials Market, Global, Clinical Trials by Sanofi, 2014*
  • Gram-Positive Bacterial Infections Therapeutics Clinical Trials Market, Global, Clinical Trials by Merck & Co., Inc., 2014*
  • Gram-Positive Bacterial Infections Therapeutics Clinical Trials Market, Global, Clinical Trials by Cubist Pharmaceuticals, Inc., 2014*
  • Gram-Positive Bacterial Infections Therapeutics Clinical Trials Market, Global, Clinical Trials by Novartis AG, 2014*
  • Gram-Positive Bacterial Infections Therapeutics Clinical Trials Market, Global, Clinical Trials by Theravance, Inc., 2014*
  • Gram-Positive Bacterial Infections Therapeutics Clinical Trials Market, Global, Clinical Trials by AstraZeneca PLC, 2014*
  • Gram-Positive Bacterial Infections Therapeutics Clinical Trials Market, Global, Clinical Trials by Emergent BioSolutions Inc., 2014*
  • Gram-Positive Bacterial Infections Therapeutics Clinical Trials Market, Global, Clinical Trials by Astellas Pharma Inc., 2014*
  • Gram-Positive Bacterial Infections Therapeutics Clinical Trials Market, Global, Clinical Trials by The National Institute of Allergy and Infectious Diseases, 2014*
  • Gram-Positive Bacterial Infections Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Oxford, 2014*
  • Gram-Positive Bacterial Infections Therapeutics Clinical Trials Market, Global, Clinical Trials by Health Protection Agency, 2014*
  • Gram-Positive Bacterial Infections Therapeutics Clinical Trials Market, Global, Clinical Trials by Assistance Publique - Hopitaux de Paris, 2014*
  • Gram-Positive Bacterial Infections Therapeutics Clinical Trials Market, Global, Clinical Trials by John D. Dingell VA Medical Center, 2014*
  • Gram-Positive Bacterial Infections Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Pittsburgh, 2014*
  • Gram-Positive Bacterial Infections Therapeutics Clinical Trials Market, Global, Clinical Trials by Uniformed Services University of the Health Sciences, 2014*
  • Gram-Positive Bacterial Infections Therapeutics Clinical Trials Market, Global, Clinical Trials by Johns Hopkins University, 2014*
  • Gram-Positive Bacterial Infections Therapeutics Clinical Trials Market, Global, Clinical Trials by Duke University, 2014*
  • Gram-Positive Bacterial Infections Therapeutics Clinical Trials Market, Global, Clinical Trials by Centers for Disease Control and Prevention, 2014*

List of Figures

  • Gram-Positive Bacterial Infections Therapeutics, Global, Clinical Trials by Region (%), 2014*
  • Gram-Positive Bacterial Infections Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2014*
  • Gram-Positive Bacterial Infections Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2014*
  • Gram-Positive Bacterial Infections Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2014*
  • Gram-Positive Bacterial Infections Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2014*
  • Gram-Positive Bacterial Infections Therapeutics Clinical Trials, North America, Top Countries (%), 2014*
  • Gram-Positive Bacterial Infections Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries (%), 2014*
  • Gram-Positive Bacterial Infections Therapeutics Clinical Trials, Central and South America, Top Five Countries (%), 2014*
  • Proportion of Gram-Positive Bacterial Infections to Infectious Disease Clinical Trials, G7 Countries (%), 2014*
  • Gram-Positive Bacterial Infections Therapeutics, G7 Countries, Clinical Trials by Phase, 2014*
  • Gram-Positive Bacterial Infections Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2014*
  • Proportion of Gram-Positive Bacterial Infections to Infectious Disease Clinical Trials, E7 Countries (%), 2014*
  • Gram-Positive Bacterial Infections Therapeutics, E7 Countries, Clinical Trials by Phase, 2014*
  • Gram-Positive Bacterial Infections Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2014*
  • Gram-Positive Bacterial Infections Therapeutics, Global, Clinical Trials by Phase (%), 2014*
  • Gram-Positive Bacterial Infections Therapeutics, Global, Clinical Trials In Progress by Phase, 2014*
  • Gram-Positive Bacterial Infections Therapeutics, Global, Clinical Trials by Trial Status, 2014*
  • Gram-Positive Bacterial Infections Therapeutics Clinical Trials, Global, by End Point Status, 2014*
  • Gram-Positive Bacterial Infections Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013
  • Gram-Positive Bacterial Infections Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2014*
  • Gram-Positive Bacterial Infections Therapeutics Clinical Trials, Global, Key Sponsors, 2014*
  • Gram-Positive Bacterial Infections Therapeutics Clinical Trials, Global, Top Companies by Phase, 2014*
  • Gram-Positive Bacterial Infections Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2014*
  • GlobalData Methodology
Back to Top